Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Asset Utilization Ratio (2020 - 2025)

Burning Rock Biotech has reported Asset Utilization Ratio over the past 6 years, most recently at 0.66 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 21.1% year-over-year to 0.66; the TTM value through Dec 2025 reached 0.66, up 21.1%, while the annual FY2025 figure was 0.65, 22.53% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.66 at Burning Rock Biotech, up from 0.65 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.66 in Q4 2025 and troughed at 0.17 in Q1 2021.
  • A 5-year average of 0.42 and a median of 0.44 in 2023 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: surged 67.07% in 2022 and later increased 9.63% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.21 in 2021, then skyrocketed by 66.09% to 0.36 in 2022, then skyrocketed by 38.93% to 0.5 in 2023, then increased by 9.63% to 0.54 in 2024, then increased by 21.1% to 0.66 in 2025.
  • Business Quant data shows Asset Utilization Ratio for BNR at 0.66 in Q4 2025, 0.65 in Q3 2025, and 0.64 in Q2 2025.